Lv5
1140 积分 2023-06-06 加入
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database
9天前
已完结
Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation
9天前
已完结
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome
9天前
已完结
ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
11天前
已完结
Management of immune checkpoint inhibitor–induced bullous pemphigoid
17天前
已完结
Gut Dysbiosis Exacerbates Inflammatory Liver Injury Induced by Environmentally Relevant Concentrations of Nanoplastics via the Gut-Liver Axis
2个月前
已完结